Bridgepoint Group (STU:8XW) Research & Development: €0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:8XW Bridgepoint Group PLC STU:8XW
87 GF Score
Price €3.68
GF Value €4.52
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Bridgepoint Group Research & Development?

Bridgepoint Group STU:8XW +3.37% 87 Research & Development is €0.0 Mil as of Jun. 2026. GuruFocus rates STU:8XW with a GF Score™ of 87/100 and a GF Value™ of €4.52 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bridgepoint Group's Research & Development for the six months ended in Jun. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €0.0 Mil.

Bridgepoint Group  (STU:8XW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bridgepoint Group Research & Development Related Terms

Bridgepoint Group Research & Development Historical Data

* Premium members only.

The historical data trend for Bridgepoint Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bridgepoint Group Research & Development Chart

Bridgepoint Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bridgepoint Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:8XW
87GF Score
Bridgepoint Group PLC STU:8XW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bridgepoint Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Bridgepoint Group (STU:8XW) has a Research & Development of €0.0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Bridgepoint Group and its competitors.
Is Bridgepoint Group's Research & Development too high?
Bridgepoint Group's current Research & Development is €0.0 Mil. Overall, Bridgepoint Group has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bridgepoint Group's Research & Development compare to BLK and BX?
Bridgepoint Group's Research & Development of €0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bridgepoint Group and its competitors. Bridgepoint Group's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bridgepoint Group stock overvalued right now?
Based on GuruFocus' analysis, Bridgepoint Group (STU:8XW) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.52, compared to a current price of €3.68 — trading 18.6% below its estimated fair value. The current Research & Development is €0.0 Mil. Bridgepoint Group's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bridgepoint Group (STU:8XW), the current Research & Development is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bridgepoint Group (STU:8XW) Overvalued in 2026?

Based on GuruFocus' analysis, Bridgepoint Group stock appears to be undervalued. The current stock price of €3.68 is trading 18.6% below its estimated GF Value™ of €4.52. GuruFocus considers Bridgepoint Group to be Modestly Undervalued.

Key valuation signals for STU:8XW:

  • Research & Development: €0.0 Mil
  • GF Value™: €4.52 vs. price of €3.68 (18.6% below fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the STU:8XW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bridgepoint Group Business Description

Other Exchanges BPTl:UKBPT:UK8XW:Germany
Address 5 Marble Arch, London, GBR, W1H 7EJ
Bridgepoint Group PLC is a British private investment company. It invests in the mid-market segment across areas such as private equity, private credit, infrastructure, secondaries, and private wealth strategies. The reporting segments of the company are Private Equity, Credit, and Infrastructure out of which, the company derives maximum revenue from Private equity segment.
87GF Score

Get the complete analysis for STU:8XW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.68
Price
€4.52
GF Value